Joints, loose skin, clumsiness... Why is hyperactive Ehlers-Danlos syndrome often absent?

Published Date: 29 Mar 2023

There is interest in a related condition called Ehlers-Danlos syndrome.

Read Full News

Latest News

GLP-1s Tied to Weight Loss in Real-World Rheumatologic Care

Semaglutide and tirzepatide use is rising among patients with rheumatic and musculoskeletal diseases and is linked to meaningful 1-year weight loss, especially in tirzepatide users.

FRAX Predicts Surgery Benefit in Hyperparathyroidism

The Fracture Risk Assessment Tool predictions suggest patients who don’t meet guideline criteria for parathyroidectomy may nevertheless benefit from the surgery.

Serum Acylcarnitines May Predict Kidney Decline in Diabetes

Specific serum acylcarnitine levels are linked to faster kidney function decline in type 2 diabetes and can help improve the prediction of patients at highest risk for rapid decline.

Tirzepatide Yields Early Weight Loss, Later Plateau

Modeling finds marked early weight loss with tirzepatide that later plateaus as appetite returns and energy expenditure decreases, and discontinuation of the drug is linked to partial weight regain.

The Sweetener Trap: Are Sugar Alternatives Backfiring?

Emerging evidence suggests some sugar substitutes may affect metabolism, gut microbiome, and cardiovascular health more than previously recognized.

Stigma Negatively Affects Postbariatric Outcomes

Weight bias, stigma, and discrimination are linked to poorer mental health and weight outcomes after bariatric surgery, although the long-term physical effects remain understudied.

Todays Updates

Italy's Arbovirus Threat: Is Europe at Greater Risk?

Experts say arboviral outbreaks are becoming a growing public health concern in Europe because of expanding mosquito activity and climate shifts.

Todays Updates

Italy's Arbovirus Threat: Is Europe at Greater Risk?

Experts say arboviral outbreaks are becoming a growing public health concern in Europe because of expanding mosquito activity and climate shifts.

Latest News

Semaglutide and tirzepatide use is rising among patients with rheumatic and musculoskeletal diseases and is linked to meaningful 1-year weight loss, especially in tirzepatide users.

The Fracture Risk Assessment Tool predictions suggest patients who don’t meet guideline criteria for parathyroidectomy may nevertheless benefit from the surgery.

Specific serum acylcarnitine levels are linked to faster kidney function decline in type 2 diabetes and can help improve the prediction of patients at highest risk for rapid decline.

Modeling finds marked early weight loss with tirzepatide that later plateaus as appetite returns and energy expenditure decreases, and discontinuation of the drug is linked to partial weight regain.

Emerging evidence suggests some sugar substitutes may affect metabolism, gut microbiome, and cardiovascular health more than previously recognized.

Weight bias, stigma, and discrimination are linked to poorer mental health and weight outcomes after bariatric surgery, although the long-term physical effects remain understudied.

News All Time

Private-Sector Healthcare Rise May Affect Canadians’ Trust

As the number of privately funded providers and clinics in Canada increases, it may set up a two-tier system where those who can afford to pay out of pocket may have faster access to care.

Hypothyroidism Drug May Cause Psychiatric Morbidity

The addition of liothyronine to levothyroxine treatment is associated with a higher risk for psychiatric morbidity in patients with autoimmune hypothyroidism.

Maternal Overnutrition Linked to Obesity in Adult Offspring

Maternal overnutrition is associated with a higher likelihood of obesity in adult offspring, with effects persisting into adulthood and being more pronounced in women.

French Regulators Fine Novo, Lilly Over GLP-1 Campaigns

French regulators say obesity awareness campaigns may blur the line between public education and the promotion of prescription weight-loss drugs.

EASO Update Gives Clearer Roles for Tirzepatide, Semaglutide

EASO’s ‘living’ algorithm has been updated with the latest evidence, strengthening tirzepatide’s position for weight loss and semaglutide’s role in liver fibrosis improvement.

Is Persistent Hunger After Weight Loss Behind Weight Regain?

People who regain lost weight may be biologically driven to do so via hyperphagia, an insatiable hunger and an intense preoccupation with food.

Acute Kidney Injury Sets Kids Up for Chronic Kidney Disease

A meta-analysis finds increased long-term odds of chronic kidney disease and death in children who survive acute kidney injury.

Cotrimoxazole Tied to More AEs in Older Men With UTIs

The use of cotrimoxazole is linked to about twice the risk of developing adverse events compared with the use of fluoroquinolones among older men with UTIs.

GLP-1 RAs May Independently Boost Testosterone Levels

Increases in testosterone were realized in a large cohort regardless of patient age or BMI at baseline and could not be explained just by weight loss.

New Dosing Option Okayed for X-Linked Hypophosphatemia Drug

The FDA has approved an option to increase the dose and frequency of burosumab-twza for adults whose serum phosphorus remains below normal.

BioMarin's Genetic Disease Therapy Shows Mixed Results in Late-stage Study

BioMarin Pharmaceutical said on Monday its experimental treatment for a rare genetic condition met ⁠one of the two main goals in a late-stage study.

Many Parents on Obesity Meds Discuss Treatment With Kids

Parents often discuss using obesity medications and related weight or behavior changes with their children.

Menopause Symptoms Worse in Women With Abdominal Obesity

Women with abdominal obesity report a higher burden of certain menopausal symptoms and exhibit a distinct pattern of symptom interrelationships relative to women without abdominal obesity.

Restarting GLP-1s After Stopping: How to Counsel Patients

Many patients taking GLP-1 RAs for weight loss discontinue within the first year. How can clinicians support long-term success with these drugs?

Pesticides May Help Explain Rising Early-Onset CRC Rates

A study linked a common herbicide to rising early-onset colorectal cancer, using DNA methylation to trace lifelong exposures rather than relying on patient recall.

Can Lower-Dose Tirzepatide Keep Weight Off?

New trial data suggest some patients may maintain meaningful weight loss after stepping down from the maximum dose of tirzepatide.

Recommended News For You

Is Chemotherapy via Peripheral IV Access More Effective Than Central Lines for Testicular Cancer?

Ultrasonography of hepatocellular carcinoma: From diagnosis to prognosis

More Support for Early Detection; Cancer in Men Rising; Diet Drives Colon Cancer

Financial hardship for cancer survivors due to high-cost immunotherapies, especially for blood cancer patients

Mortality up for children with leukemia from lowest SES neighborhoods

Early detection of breast cancer may be possible with AI-based mammography microcalcification detection and classification.

Achieves a High Disease Control Rate in Head and Neck BCC with Vismodegib-RT Regimen.

Recommended Articles For You

Managing KRAS Inhibitor Toxicities: Focus on Rash and Beyond 

Seeing the Unseen: The Benefits of Early Stage Breast Cancer Ultrasound 

Immuno-Oncology in Daily Practice: Transforming Cancer Care One Patient at a Time 

Obesity as a major risk factor for cancer 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Geriatric Assessment, QoL Correlate With OS in Older Patients with Pancreatic Cancer

2.

Higher Binge Drinking Rates Linked to New Cannabis Laws.

3.

Cancer Patients Who Completed Medication Survey Received More Help From Pharmacists

4.

Ketamine plus psychotherapy for "excellent" PTSD

5.

No Seed Oil-Colon Cancer Link; Avoiding Prostate Biopsy; Top Cancer Advances

1.

Revolutionizing Oncology: Pharmacometric Models in Personalized Cancer Drug Development

2.

HPV-Related Cervical Cancer: Advances in Screening, Preventiofn & Treatment

3.

Advancing Cancer Trials: Integrating Master Protocols and Immunotherapy Guidelines

4.

Navigating the Stages of Thyroid Cancer: A Guide for Patients

5.

Can We Repurpose BV-CHP for Better Outcomes in Peripheral T-Cell Lymphoma?

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

A New Era in Managing Cancer-Associated Thrombosis

2.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VI

3.

Current Scenario of Cancer- Final Discussion on the Importance of Genomic Testing & Advancement in Diagnosis and Treatment

4.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV

5.

An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot